When was Harmonic Discovery founded?

Harmonic Discovery was founded in 2021 and raised its 1st funding round within a year of its incorporation.

Where is Harmonic Discovery located?

Harmonic Discovery is headquartered in New York City, United States.

Who is the current CEO of Harmonic Discovery?

Rayees Rahman of Harmonic Discovery. They have also founded 2 companies.

How many employees does Harmonic Discovery have?

As of Aug 31, 2026, the latest employee count at Harmonic Discovery is 5.

Is Harmonic Discovery a funded company?

Harmonic Discovery is a funded company, having raised a total of $8.12M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2021.

How much is Harmonic Discovery worth?

The latest valuation of Harmonic Discovery is $***** as of Jan 01, 2021.

When was the latest funding round of Harmonic Discovery?

Harmonic Discovery's latest funding was a $***** Seed round on Sep 08, 2022, with participation from 5 investors.

Where does Harmonic Discovery rank among its competitors?

Harmonic Discovery ranks 911th amongst 3312 active competitors, of which 1118 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of Harmonic Discovery?

Harmonic Discovery's top competitors include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

Harmonic Discovery - 2026 Company Profile, Team, Funding & Competitors

Harmonic Discovery is a seed company based in New York City (United States), founded in 2021 by Rayees Rahman, Marcel Patek and Jason Lee. It operates as a Developer of kinase inhibitor drugs for oncology. Harmonic Discovery has raised $8.12M in funding from Y Combinator and Innovation Endeavors, with a current valuation of $*****. The company has 3312 active competitors, including 1118 funded and 783 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.

Company Details

Developer of kinase inhibitor drugs for oncology. The company's platform integrates biological screening and medicinal chemistry with computational chemistry to predict clinical resistance mutations and optimize the design of small molecule therapeutics to maintain binding to their key targets and avoid harmful off-target interactions, enabling medical practitioners to treat cancer more effectively.

Website: harmonicdiscovery.com
Social

Key Metrics

Founded Year

2021

Location

New York City, United States

Stage

Seed

Total Funding

$8.12M in 2 rounds

Latest Funding Round

Seed, Sep 08, 2022, $*****

Post Money Valuation

$***** as on Jan 01, 2021

Investors

Y Combinator & 4 more

Ranked

911^th among 3312 active competitors

Employee Count

5 as on Aug 31, 2026

Similar Companies

Jazz Pharmaceuticals & 3003 more

View Harmonic Discovery's full profile

Harmonic Discovery is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
HARMONIC DISCOVERY CIN: 86-3992171 , United States, Active	Mar 15, 2022	-	7 (As on Dec 31, 2022)	-

Harmonic Discovery has raised a total funding of $8.12M over 2 rounds. Its first funding round was on 2021. Its latest funding round was a Seed round on Sep 08, 2022 for $*****. 5 investors participated in its latest round. Harmonic Discovery has 5 institutional investors.

Here is the list of recent funding rounds of Harmonic Discovery:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 08, 2022	4652893	Seed	6188427	6904420	2528302	6871836
2021	3671	Seed	4508	2838	Y Combinator	8333

Access funding benchmarks and valuations. Sign up today!

View details of Harmonic Discovery's funding rounds and investors

The founders of Harmonic Discovery are Rayees Rahman, Marcel Patek and Jason Lee. Rayees Rahman is the CEO of Harmonic Discovery.

Here are the details of Harmonic Discovery's key team members:

Rayees Rahman: Co-Founder & CEO of Harmonic Discovery and founder of 1 other company.
Contact Info: 1 email address
Marcel Patek: Co-Founder & CSO of Harmonic Discovery.
Contact Info: 1 email address
Jason Lee: Co-Founder & COO of Harmonic Discovery.
Contact Info: 1 email address

View details of Harmonic Discovery's Founder profiles and Board Members

Harmonic Discovery's employee count trend

Harmonic Discovery has 5 employees as of Aug 26. Here is Harmonic Discovery's employee count trend over the years:

Employee count trend for Harmonic Discovery

Uncover Harmonic Discovery's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Harmonic Discovery include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Harmonic Discovery, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	BeiGene 2010, Cambridge (United States), Public	Developer of targeted and immune-oncology drugs against cancer	$172M	Hillhouse, T. Rowe Price & 13 others	80/100
3rd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, F-Prime Capital & 18 others	73/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
5th	Senti Bio 2016, San Francisco (United States), Public	Developer of cell and gene therapies for patients living with incurable diseases	$158M	Celadon Partners, New Enterprise Associates ... & 30 others	72/100
6th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
7th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
8th	Moderna 2010, Cambridge (United States), Public	Developer of mRNA-based therapeutics for a wide range of diseases	$2.78B	Merck, AstraZeneca & 32 others	71/100
9th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	71/100
10th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
911th	Harmonic Discovery 2021, New York City (United States), Seed	Developer of kinase inhibitor drugs for oncology	$8.12M	Innovation Endeavors, Caffeinated Capital ... & 3 others	42/100